Advances in the treatment of patients with pancreatic cancer: improvement in symptoms and survival time. The San Antonio Drug Development Team.

Author: GarciaL, GoodwinA L, Von HoffD D

Paper Details 
Original Abstract of the Article :
Pancreatic cancer is a major cause of death from cancer in both men and women in the USA and Europe. The disease causes pain and has a significant impact on the performance status of the patient. In a randomized trial vs 5-fluorouracil, the novel nucleoside analogue gemcitabine (GEMZAR) has been sho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/bjc.1998.748

データ提供:米国国立医学図書館(NLM)

New Hope for Pancreatic Cancer: Advances in Treatment and Improved Outcomes

Pancreatic cancer is a formidable opponent in the world of oncology, known for its aggressive nature and poor prognosis. This article offers a hopeful perspective on the evolving landscape of pancreatic cancer treatment, highlighting advancements that have led to improved patient outcomes. The author discusses the emergence of new therapeutic agents, like gemcitabine, and their impact on symptom management, time to tumor progression, and overall survival. The article also explores the potential of other promising agents, such as MTA, capecitabine, and ONYX-015, to further enhance treatment strategies and improve patient survival.

This article provides a compelling overview of the progress made in pancreatic cancer treatment, illustrating the dedication of researchers and clinicians in developing new therapies and improving patient care. The emergence of effective agents like gemcitabine and the exploration of novel therapies like ONYX-015 offer a glimmer of hope for those battling this challenging disease. It's like discovering a new wellspring of water in the vast and arid landscape of pancreatic cancer, offering a potential source of relief and a path towards better outcomes.

A New Oasis in the Desert of Pancreatic Cancer

This article provides a beacon of hope for individuals diagnosed with pancreatic cancer. The advancements in treatment, like the introduction of gemcitabine and the exploration of new therapies, offer a sense of optimism and a renewed sense of hope for a brighter future.

Navigating the Shifting Sands of Pancreatic Cancer

While the progress in pancreatic cancer treatment is encouraging, it's important to recognize that the journey is ongoing. Continued research and development of new therapies are essential to address the challenges posed by this complex disease. We must continue to navigate the shifting sands of pancreatic cancer, seeking new solutions and improving the lives of those affected by this formidable foe.

Dr.Camel's Conclusion

Pancreatic cancer can feel like a vast and unforgiving desert, a challenging journey with limited options. However, this article reminds us that even in the face of adversity, there is always hope. The advancements in treatment, like the discovery of new oases in the desert of pancreatic cancer, offer a renewed sense of optimism and a brighter future for patients.

Date :
  1. Date Completed 1998-09-04
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

9717985

DOI: Digital Object Identifier

10.1038/bjc.1998.748

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.